STRUCTURE OF EVERNINOMICIN DGANGULY AK; SARRE OZ; GREEVES D et al.1975; J. AMER. CHEM. SOC.; U.S.A.; DA. 1975; VOL. 97; NO 7; PP. 1982-1985; BIBL. 14REF.Article

DC POLAROGRAPHIC DETERMINATION OF HYDROXYLAMINOEVERNINOMICIN D.KABASAKALIAN P; KALLINEY S; MAGATTI AW et al.1978; J. PHARM. SOC.; USA; DA. 1978; VOL. 67; NO 5; PP. 719-721; BIBL. 8 REF.Article

Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (ziracin), in healthy subjectsKOZAWA, Osamu; UEMATSU, Toshihiko; MATSUNO, Hiroyuki et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 3, pp 917-921, issn 0066-4804Article

Multiple-stage mass spectrometric analysis of complex oligosaccharide antibiotics (Everninomicins) in a quadrupole ion trapGUODONG CHEN; PRAMANIK, Birendra N; BARTNER, Peter L et al.Journal of the American Society for Mass Spectrometry. 2002, Vol 13, Num 11, pp 1313-1321, issn 1044-0305, 9 p.Article

Susceptibility of pneumococci to evernimicin: effect of CO₂ and different methodologiesHAMILTON-MILLER, J. M. T; SHAH, S; LOEBENBERG, D et al.Clinical microbiology and infection. 2001, Vol 7, Num 6, pp 339-340, issn 1198-743XArticle

Evernimicin (SCH27899) inhibits a novel ribosome target site : Analysis of 23S ribosomal DNA mutantsADRIAN, Peter V; MENDRICK, Cara; LOEBENBERG, David et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 11, pp 3101-3106, issn 0066-4804Article

In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumoniaERJIAN WANG; SIMARD, M; BERGERON, Y et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 4, pp 1010-1018, issn 0066-4804Article

Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolonesKENNY, George E; CARTWRIGHT, Frank D.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 9, pp 2604-2608, issn 0066-4804Article

Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J miceBRIELAND, J. K; LOEBENBERG, D; MENZEL, F et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1333-1336, issn 0066-4804Article

Glucosyloxyséléniation de D-glucals : application aux synthèses de 2'-désoxy-α-D-disaccharides et de spiro-orthoesters anomériques, fragments d'orthosomycines = Glycosyloxyseleniation of D-glucals: application to the syntheses of 2'-deoxy-α-D-disaccharides and anomeric spiro-orthoesters, orthosomycin fragmentsJAURAND, Guy.1984, 100 pThesis

GLYCOSYLOXYSELENIATION DU D-GLUCAL: SYNTHESE DE 2'-DESOXY-ALPHA -GLYCOSIDES ET D'ORTHOESTERS COMPLEXES = GLYCOSYLOXYSELENENYLATION OF D-GLUCAL: SYNTHESIS OF 2'-DEOXY-ALPHA -GLYCOSIDES AND COMPLEX ORTHOESTERSJAURAND GUY.1982; ; FRA; DA. 1982; 98 P.; 30 CM; BIBL. 44 REF.; TH. 3E CYCLE: CHIM. ORG./PARIS 11/1982/3269Thesis